Build Your Comparison

Side-by-side financial analysis
MACI logo
MACI
MS logo
MS
Try popular comparisons:

Stock Comparison

MACI vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MACI
Melar Acquisition Corp. I

Shell Companies

Financial ServicesNASDAQ • KY
Market Cap$238M
5Y Perf.+10.2%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$340.97B
5Y Perf.+107.4%

MACI vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MACI logoMACI
MS logoMS
IndustryShell CompaniesFinancial - Capital Markets
Market Cap$238M$340.97B
Revenue (TTM)$0.00$114.98B
Net Income (TTM)$5M$16.86B
Gross Margin57.1%
Operating Margin19.1%
Forward P/E42.3x18.0x
Total Debt$4M$475.56B
Cash & Equiv.$32K$111.69B

MACI vs MSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MACI
MS
StockJul 24Jun 26Return
Melar Acquisition C… (MACI)100110.2+10.2%
Morgan Stanley (MS)100207.4+107.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: MACI vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MS leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Melar Acquisition Corp. I is the stronger pick specifically for capital preservation and lower volatility and operational efficiency and capital deployment. As sector peers, any of these can serve as alternatives in the same allocation.
🥇MS emerged as the overall leader. Track its performance:
MACI
Melar Acquisition Corp. I
The Banking Pick

MACI is the clearest fit if your priority is income & stability and growth exposure.

  • beta 0.01
  • EPS growth 36.8%
  • Lower volatility, beta 0.01, Low D/E 2.3%, current ratio 0.91x
Best for: income & stability and growth exposure
MS
Morgan Stanley
The Banking Pick

MS carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 8.5% 10Y total return vs MACI's 10.4%
  • 11.5% NII/revenue growth vs MACI's -65.2%
  • Lower P/E (18.0x vs 42.3x)
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthMS logoMS11.5% NII/revenue growth vs MACI's -65.2%
ValueMS logoMSLower P/E (18.0x vs 42.3x)
Quality / MarginsMS logoMS14.7% margin vs MACI's 4.0%
Stability / SafetyMACI logoMACIBeta 0.01 vs MS's 1.40, lower leverage
DividendsMS logoMS1.9% yield; 12-year raise streak; the other pay no meaningful dividend
Momentum (1Y)MS logoMS+65.3% vs MACI's +5.5%
Efficiency (ROA)MACI logoMACI2.7% ROA vs MS's 1.2%, ROIC -0.7% vs 3.1%

MACI vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MACIMelar Acquisition Corp. I

Segment breakdown not available.

MSMorgan Stanley
FY 2025
Institutional Securities Segment
46.4%$33.1B
Wealth Management Segment
44.5%$31.8B
Investment Management Segment
9.1%$6.5B

MACI vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMSLAGGINGMACI

Income & Cash Flow (Last 12 Months)

MS leads this category, winning 1 of 1 comparable metric.

MS and MACI operate at a comparable scale, with $115.0B and $0 in trailing revenue.

MetricMACI logoMACIMelar Acquisition…MS logoMSMorgan Stanley
RevenueTrailing 12 months$0$115.0B
EBITDAEarnings before interest/tax$4M$26.6B
Net IncomeAfter-tax profit$5M$16.9B
Free Cash FlowCash after capex-$681,989-$17.9B
Gross MarginGross profit ÷ Revenue+57.1%
Operating MarginEBIT ÷ Revenue+19.1%
Net MarginNet income ÷ Revenue+14.7%
FCF MarginFCF ÷ Revenue-15.6%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-45.3%+48.9%
MS leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

Evenly matched — MACI and MS each lead in 1 of 2 comparable metrics.

At 21.0x trailing earnings, MS trades at a 50% valuation discount to MACI's 42.3x P/E.

MetricMACI logoMACIMelar Acquisition…MS logoMSMorgan Stanley
Market CapShares × price$238M$341.0B
Enterprise ValueMkt cap + debt − cash$242M$704.8B
Trailing P/EPrice ÷ TTM EPS42.31x20.98x
Forward P/EPrice ÷ next-FY EPS est.18.00x
PEG RatioP/E ÷ EPS growth rate2.19x
EV / EBITDAEnterprise value multiple26.49x
Price / SalesMarket cap ÷ Revenue2.97x
Price / BookPrice ÷ Book value/share1.07x3.03x
Price / FCFMarket cap ÷ FCF7.40x
Evenly matched — MACI and MS each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

MACI leads this category, winning 5 of 9 comparable metrics.

MS delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $3 for MACI. MACI carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 4.22x. On the Piotroski fundamental quality scale (0–9), MS scores 7/9 vs MACI's 4/9, reflecting strong financial health.

MetricMACI logoMACIMelar Acquisition…MS logoMSMorgan Stanley
ROE (TTM)Return on equity+2.9%+15.3%
ROA (TTM)Return on assets+2.7%+1.2%
ROICReturn on invested capital-0.7%+3.1%
ROCEReturn on capital employed-0.9%+3.3%
Piotroski ScoreFundamental quality 0–947
Debt / EquityFinancial leverage0.02x4.22x
Net DebtTotal debt minus cash$4M$363.9B
Cash & Equiv.Liquid assets$32,075$111.7B
Total DebtShort + long-term debt$4M$475.6B
Interest CoverageEBIT ÷ Interest expense5.43x0.45x
MACI leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

MS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MS five years ago would be worth $25,467 today (with dividends reinvested), compared to $11,044 for MACI. Over the past 12 months, MS leads with a +65.3% total return vs MACI's +5.5%. The 3-year compound annual growth rate (CAGR) favors MS at 37.1% vs MACI's 3.4% — a key indicator of consistent wealth creation.

MetricMACI logoMACIMelar Acquisition…MS logoMSMorgan Stanley
YTD ReturnYear-to-date+3.6%+18.8%
1-Year ReturnPast 12 months+5.5%+65.3%
3-Year ReturnCumulative with dividends+10.4%+157.5%
5-Year ReturnCumulative with dividends+10.4%+154.7%
10-Year ReturnCumulative with dividends+10.4%+854.4%
CAGR (3Y)Annualised 3-year return+3.4%+37.1%
MS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MACI and MS each lead in 1 of 2 comparable metrics.

MACI is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than MS's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricMACI logoMACIMelar Acquisition…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5000.01x1.40x
52-Week HighHighest price in past year$11.38$219.16
52-Week LowLowest price in past year$10.43$128.81
% of 52W HighCurrent price vs 52-week peak+96.7%+97.7%
RSI (14)Momentum oscillator 0–10042.262.2
Avg Volume (50D)Average daily shares traded18K4.5M
Evenly matched — MACI and MS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

MS is the only dividend payer here at 1.93% yield — a key consideration for income-focused portfolios.

MetricMACI logoMACIMelar Acquisition…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$201.25
# AnalystsCovering analysts52
Dividend YieldAnnual dividend ÷ price+1.9%
Dividend StreakConsecutive years of raises12
Dividend / ShareAnnual DPS$4.14
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.7%
Insufficient data to determine a leader in this category.
Key Takeaway

MS leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MACI leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallMorgan Stanley (MS)Leads 2 of 6 categories
Loading custom metrics...

MACI vs MS: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is MACI or MS a better buy right now?

Morgan Stanley (MS) offers the better valuation at 21.

0x trailing P/E (18. 0x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MACI or MS?

On trailing P/E, Morgan Stanley (MS) is the cheapest at 21.

0x versus Melar Acquisition Corp. I at 42. 3x.

03

Which is the better long-term investment — MACI or MS?

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +154.

7%, compared to +10. 4% for Melar Acquisition Corp. I (MACI). Over 10 years, the gap is even starker: MS returned +854. 4% versus MACI's +10. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MACI or MS?

By beta (market sensitivity over 5 years), Melar Acquisition Corp.

I (MACI) is the lower-risk stock at 0. 01β versus Morgan Stanley's 1. 40β — meaning MS is approximately 10214% more volatile than MACI relative to the S&P 500. On balance sheet safety, Melar Acquisition Corp. I (MACI) carries a lower debt/equity ratio of 2% versus 4% for Morgan Stanley — giving it more financial flexibility in a downturn.

05

Which is growing faster — MACI or MS?

On earnings-per-share growth, the picture is similar: Melar Acquisition Corp.

I grew EPS 36. 8% year-over-year, compared to 28. 3% for Morgan Stanley. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MACI or MS?

Morgan Stanley (MS) is the more profitable company, earning 14.

7% net margin versus 0. 0% for Melar Acquisition Corp. I — meaning it keeps 14. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 19. 1% versus 0. 0% for MACI. At the gross margin level — before operating expenses — MS leads at 57. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Which pays a better dividend — MACI or MS?

In this comparison, MS (1.

9% yield) pays a dividend. MACI does not pay a meaningful dividend and should not be held primarily for income.

08

Is MACI or MS better for a retirement portfolio?

For long-horizon retirement investors, Melar Acquisition Corp.

I (MACI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01)). Both have compounded well over 10 years (MACI: +10. 4%, MS: +854. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between MACI and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

MS pays a dividend while MACI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.